Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 15 | 2021 | 113 | 3.360 |
Why?
|
| Myosin Type I | 4 | 2021 | 20 | 2.050 |
Why?
|
| Doxorubicin | 5 | 2019 | 231 | 1.450 |
Why?
|
| Kidney Diseases | 5 | 2019 | 307 | 1.320 |
Why?
|
| Membrane Proteins | 8 | 2021 | 617 | 1.280 |
Why?
|
| Glomerulonephritis | 2 | 2019 | 77 | 1.170 |
Why?
|
| Signal Transduction | 10 | 2021 | 2689 | 1.070 |
Why?
|
| Kidney Glomerulus | 5 | 2021 | 155 | 0.920 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 6 | 2010 | 207 | 0.910 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2019 | 34 | 0.830 |
Why?
|
| Puromycin Aminonucleoside | 2 | 2019 | 7 | 0.820 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 2 | 2019 | 27 | 0.810 |
Why?
|
| Transcriptome | 2 | 2020 | 164 | 0.780 |
Why?
|
| Transforming Growth Factor beta | 2 | 2021 | 384 | 0.700 |
Why?
|
| Formoterol Fumarate | 1 | 2019 | 25 | 0.670 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2019 | 18 | 0.660 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2016 | 786 | 0.650 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2010 | 627 | 0.620 |
Why?
|
| Zebrafish | 4 | 2017 | 187 | 0.600 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 301 | 0.600 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 161 | 0.600 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1293 | 0.570 |
Why?
|
| Zebrafish Proteins | 2 | 2014 | 100 | 0.550 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 232 | 0.540 |
Why?
|
| Fibroblasts | 1 | 2021 | 902 | 0.540 |
Why?
|
| Kidney | 3 | 2021 | 945 | 0.530 |
Why?
|
| Liver | 1 | 2021 | 1118 | 0.520 |
Why?
|
| Phosphorylation | 7 | 2021 | 1200 | 0.510 |
Why?
|
| Glomerular Basement Membrane | 2 | 2019 | 10 | 0.510 |
Why?
|
| Mitochondria | 2 | 2019 | 643 | 0.500 |
Why?
|
| Mice | 13 | 2021 | 8474 | 0.450 |
Why?
|
| Animals | 18 | 2021 | 20881 | 0.440 |
Why?
|
| Polymorphism, Genetic | 4 | 2010 | 301 | 0.430 |
Why?
|
| Oxidative Stress | 5 | 2010 | 718 | 0.410 |
Why?
|
| Cell Line | 8 | 2021 | 1752 | 0.390 |
Why?
|
| Nephrotic Syndrome | 2 | 2019 | 61 | 0.320 |
Why?
|
| Renal Agents | 2 | 2019 | 8 | 0.320 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 160 | 0.300 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2007 | 11 | 0.290 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2007 | 11 | 0.290 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 231 | 0.280 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2007 | 102 | 0.270 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 2550 | 0.250 |
Why?
|
| Genotype | 6 | 2013 | 786 | 0.250 |
Why?
|
| Humans | 24 | 2021 | 68618 | 0.250 |
Why?
|
| Protein Binding | 5 | 2021 | 1027 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1692 | 0.210 |
Why?
|
| Gene Frequency | 4 | 2019 | 207 | 0.210 |
Why?
|
| Zonula Occludens-1 Protein | 3 | 2017 | 25 | 0.190 |
Why?
|
| Apoptosis | 5 | 2020 | 1641 | 0.190 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 63 | 0.190 |
Why?
|
| Photoreceptor Cells | 1 | 2021 | 62 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 196 | 0.180 |
Why?
|
| Rhodopsin | 1 | 2021 | 135 | 0.180 |
Why?
|
| Hepatic Stellate Cells | 1 | 2021 | 53 | 0.180 |
Why?
|
| Fibrosis | 2 | 2019 | 371 | 0.180 |
Why?
|
| Eye Proteins | 1 | 2021 | 160 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 615 | 0.180 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2019 | 51 | 0.170 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 34 | 0.170 |
Why?
|
| Retina | 1 | 2021 | 252 | 0.170 |
Why?
|
| Protein Transport | 2 | 2019 | 280 | 0.170 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 118 | 0.160 |
Why?
|
| Myofibroblasts | 1 | 2019 | 60 | 0.160 |
Why?
|
| Lipoproteins | 1 | 2020 | 161 | 0.160 |
Why?
|
| Scattering, Small Angle | 2 | 2016 | 10 | 0.160 |
Why?
|
| Calcium Signaling | 1 | 2019 | 97 | 0.160 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2010 | 53 | 0.160 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2019 | 43 | 0.160 |
Why?
|
| Drug Resistance | 1 | 2019 | 223 | 0.160 |
Why?
|
| Biological Assay | 1 | 2019 | 88 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 87 | 0.160 |
Why?
|
| Gene Deletion | 1 | 2019 | 235 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 163 | 0.150 |
Why?
|
| India | 2 | 2008 | 41 | 0.150 |
Why?
|
| Isodesmosine | 1 | 2017 | 6 | 0.150 |
Why?
|
| Haplotypes | 2 | 2008 | 174 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2019 | 222 | 0.150 |
Why?
|
| Protective Agents | 1 | 2017 | 36 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 48 | 0.150 |
Why?
|
| Glutamyl Aminopeptidase | 1 | 2017 | 12 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 161 | 0.140 |
Why?
|
| Benzazepines | 1 | 2017 | 104 | 0.140 |
Why?
|
| Binding Sites | 2 | 2016 | 631 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 562 | 0.140 |
Why?
|
| Sphingolipids | 1 | 2020 | 337 | 0.140 |
Why?
|
| Indoles | 1 | 2017 | 146 | 0.140 |
Why?
|
| Drug Discovery | 1 | 2017 | 94 | 0.140 |
Why?
|
| X-Ray Diffraction | 1 | 2016 | 53 | 0.130 |
Why?
|
| Ceramides | 1 | 2020 | 578 | 0.130 |
Why?
|
| Point Mutation | 1 | 2016 | 97 | 0.130 |
Why?
|
| Species Specificity | 1 | 2016 | 303 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1034 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2007 | 499 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2673 | 0.120 |
Why?
|
| Models, Molecular | 1 | 2016 | 546 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 807 | 0.120 |
Why?
|
| Membrane Microdomains | 1 | 2014 | 32 | 0.120 |
Why?
|
| Male | 12 | 2019 | 37321 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 77 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 2791 | 0.110 |
Why?
|
| Female | 10 | 2019 | 38074 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 3 | 2021 | 274 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2010 | 1553 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2012 | 202 | 0.100 |
Why?
|
| Glutathione | 2 | 2010 | 343 | 0.090 |
Why?
|
| Malaria, Vivax | 1 | 2010 | 3 | 0.090 |
Why?
|
| Malaria, Falciparum | 1 | 2010 | 10 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2010 | 1 | 0.090 |
Why?
|
| Smad1 Protein | 1 | 2010 | 10 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2010 | 20 | 0.090 |
Why?
|
| Smad2 Protein | 1 | 2010 | 42 | 0.090 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2010 | 4 | 0.090 |
Why?
|
| Joint Diseases | 1 | 2010 | 37 | 0.090 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2010 | 14 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 2010 | 80 | 0.080 |
Why?
|
| Thiophenes | 1 | 2009 | 76 | 0.080 |
Why?
|
| Genes, p53 | 1 | 2008 | 41 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2010 | 201 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 56 | 0.080 |
Why?
|
| Antioxidants | 2 | 2007 | 304 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2009 | 152 | 0.080 |
Why?
|
| Myocardium | 2 | 2019 | 1204 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 202 | 0.080 |
Why?
|
| Homeostasis | 1 | 2009 | 291 | 0.070 |
Why?
|
| Epoxide Hydrolases | 1 | 2007 | 8 | 0.070 |
Why?
|
| Alleles | 1 | 2008 | 386 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2007 | 90 | 0.070 |
Why?
|
| Ischemia | 1 | 2008 | 229 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2009 | 295 | 0.070 |
Why?
|
| Cytochrome P-450 CYP11B2 | 1 | 2006 | 1 | 0.070 |
Why?
|
| Altitude Sickness | 1 | 2006 | 5 | 0.070 |
Why?
|
| Altitude | 1 | 2006 | 17 | 0.070 |
Why?
|
| Hypoxia | 1 | 2007 | 169 | 0.070 |
Why?
|
| Anemia, Sickle Cell | 1 | 2010 | 364 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 159 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 189 | 0.060 |
Why?
|
| Phenotype | 2 | 2021 | 947 | 0.060 |
Why?
|
| Proteinuria | 2 | 2019 | 136 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2007 | 867 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2009 | 1451 | 0.050 |
Why?
|
| Disease Progression | 2 | 2019 | 1038 | 0.050 |
Why?
|
| Adult | 6 | 2010 | 21403 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2021 | 32 | 0.050 |
Why?
|
| Dyneins | 1 | 2021 | 10 | 0.050 |
Why?
|
| Electroretinography | 1 | 2021 | 122 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1664 | 0.050 |
Why?
|
| Carbon Isotopes | 1 | 2020 | 54 | 0.040 |
Why?
|
| Focal Adhesions | 1 | 2020 | 25 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2019 | 4 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 112 | 0.040 |
Why?
|
| Middle Aged | 5 | 2010 | 21147 | 0.040 |
Why?
|
| Hypertension | 1 | 2009 | 1535 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 12 | 0.040 |
Why?
|
| Rats | 3 | 2017 | 5300 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 56 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2019 | 41 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2019 | 59 | 0.040 |
Why?
|
| Glycolysis | 1 | 2019 | 79 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 114 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 159 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 127 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 119 | 0.040 |
Why?
|
| Biomarkers | 3 | 2010 | 1593 | 0.040 |
Why?
|
| Exocytosis | 1 | 2019 | 34 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 176 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 188 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 113 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 58 | 0.040 |
Why?
|
| Luciferases | 1 | 2019 | 105 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 46 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 186 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 191 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 88 | 0.040 |
Why?
|
| Peptides | 1 | 2021 | 455 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 193 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 392 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 57 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 214 | 0.040 |
Why?
|
| Aged | 3 | 2009 | 14862 | 0.040 |
Why?
|
| Protein Domains | 1 | 2017 | 74 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2017 | 37 | 0.040 |
Why?
|
| Microtubules | 1 | 2017 | 104 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2017 | 78 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 134 | 0.040 |
Why?
|
| Respiratory Function Tests | 2 | 2007 | 123 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 498 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 630 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 948 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 179 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 365 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1140 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 1213 | 0.030 |
Why?
|
| Glomerular Filtration Barrier | 1 | 2013 | 3 | 0.030 |
Why?
|
| Morpholinos | 1 | 2013 | 8 | 0.030 |
Why?
|
| Permeability | 1 | 2013 | 131 | 0.030 |
Why?
|
| Edema | 1 | 2013 | 66 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2013 | 159 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3259 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 3187 | 0.030 |
Why?
|
| PDZ Domains | 1 | 2012 | 5 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 136 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 328 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 839 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2012 | 397 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 103 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 137 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 71 | 0.020 |
Why?
|
| Monocytes | 1 | 2010 | 210 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2009 | 95 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2008 | 13 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2009 | 112 | 0.020 |
Why?
|
| Child | 1 | 2019 | 6405 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 682 | 0.020 |
Why?
|
| Lipid Peroxides | 1 | 2007 | 19 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2007 | 39 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2007 | 94 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2008 | 525 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 8912 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 91 | 0.020 |
Why?
|
| Aldosterone | 1 | 2006 | 51 | 0.020 |
Why?
|
| Acute Disease | 1 | 2007 | 658 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 2083 | 0.010 |
Why?
|
| Lung | 1 | 2007 | 849 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 5731 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 4848 | 0.010 |
Why?
|